1. Home
  2. USLM vs FOLD Comparison

USLM vs FOLD Comparison

Compare USLM & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • USLM
  • FOLD
  • Stock Information
  • Founded
  • USLM 1948
  • FOLD 2002
  • Country
  • USLM United States
  • FOLD United States
  • Employees
  • USLM N/A
  • FOLD N/A
  • Industry
  • USLM Other Metals and Minerals
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • USLM Industrials
  • FOLD Health Care
  • Exchange
  • USLM Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • USLM 3.0B
  • FOLD 2.8B
  • IPO Year
  • USLM N/A
  • FOLD 2007
  • Fundamental
  • Price
  • USLM $150.33
  • FOLD $9.50
  • Analyst Decision
  • USLM
  • FOLD Strong Buy
  • Analyst Count
  • USLM 0
  • FOLD 8
  • Target Price
  • USLM N/A
  • FOLD $17.57
  • AVG Volume (30 Days)
  • USLM 99.7K
  • FOLD 2.4M
  • Earning Date
  • USLM 10-30-2024
  • FOLD 11-06-2024
  • Dividend Yield
  • USLM 0.13%
  • FOLD N/A
  • EPS Growth
  • USLM 43.42
  • FOLD N/A
  • EPS
  • USLM 3.44
  • FOLD N/A
  • Revenue
  • USLM $303,351,000.00
  • FOLD $493,671,000.00
  • Revenue This Year
  • USLM N/A
  • FOLD $33.97
  • Revenue Next Year
  • USLM N/A
  • FOLD $21.74
  • P/E Ratio
  • USLM $40.62
  • FOLD N/A
  • Revenue Growth
  • USLM 10.74
  • FOLD 32.58
  • 52 Week Low
  • USLM $41.91
  • FOLD $9.02
  • 52 Week High
  • USLM $151.47
  • FOLD $14.57
  • Technical
  • Relative Strength Index (RSI)
  • USLM 78.47
  • FOLD 28.33
  • Support Level
  • USLM $137.85
  • FOLD $9.37
  • Resistance Level
  • USLM $145.63
  • FOLD $9.68
  • Average True Range (ATR)
  • USLM 6.74
  • FOLD 0.49
  • MACD
  • USLM 0.55
  • FOLD -0.18
  • Stochastic Oscillator
  • USLM 97.48
  • FOLD 3.96

About USLM United States Lime & Minerals Inc.

United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime, and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: